{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:24:46Z","timestamp":1786973086297,"version":"build-2736575974"},"reference-count":54,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background\/objectives: Multidrug-resistant and extensively drug-resistant Gram-negative pathogens are a major cause of severe ocular infections, yet treatment options are increasingly compromised by escalating antibiotic resistance. Membrane-active peptides (colistin and Mel4) offer the potential to restore antibiotic susceptibility. This study investigated the efficacy of peptide- and colistin-based adjuvant strategies in enhancing the activity of conventional antibiotics. Methods: Antibacterial activity was assessed using MIC\/MBC testing, checkerboard assays, time\u2013kill kinetics, and biofilm disruption studies, supported by confocal microscopy. Toxicity was assessed using L929 fibroblasts and red blood cells. A mechanistic study was performed with a membrane permeability assay. Results: Clinical isolates of Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae showed high resistance to six antibiotic classes (up to MICs &gt; 2048 mg\/L), while polymyxin B and colistin remained active (MIC \u2264 2 mg\/L). Mel4 displayed variable activity (MIC 7.8\u2013500 mg\/L). A total of 102 antibiotic\u2013antibiotic, antibiotic\u2013Mel4, and antibiotic\u2013colistin combination tests were performed, of which 45 showed synergistic interactions. Combining traditional antimicrobials with either colistin or Mel4 restored antibiotic susceptibility, reducing MICs up to 2048-fold. Aminoglycoside\u2013colistin combinations significantly lowered MICs, especially against K. pneumoniae. Time\u2013kill assays confirmed rapid bactericidal effects (&gt;3 log10 reduction in 3 h). The ciprofloxacin\u2013Mel4 combination effectively disrupted biofilms (62\u201392%) with low toxicity and high cell viability. Membrane permeability assays showed that ciprofloxacin has limited activity, whereas both Mel4 and the ciprofloxacin\u2013Mel4 combination showed enhanced activity across concentration gradients and over time. Conclusions: Membrane-active antimicrobials, colistin and Mel4, enhance conventional antibiotics against multidrug- and extensively drug-resistant ocular Gram-negative pathogens by restoring susceptibility, accelerating bactericidal effects, and disrupting biofilms. With low toxicity, these combinations represent promising therapeutic strategies for severe multidrug-resistant ocular infections.<\/jats:p>","DOI":"10.3390\/antibiotics15080793","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:01:26Z","timestamp":1786968086000},"page":"793","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting WHO-Priority MDR and XDR Gram-Negative Ocular Isolates by Combining Conventional Antimicrobials with Membrane-Active Peptides"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4350-9803","authenticated-orcid":false,"given":"Teshome Belachew","family":"Eshete","sequence":"first","affiliation":[{"name":"School of Optometry and Vision Science, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3888-7319","authenticated-orcid":false,"given":"Shyam Kumar","family":"Mishra","sequence":"additional","affiliation":[{"name":"School of Optometry and Vision Science, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia"},{"name":"Department of Microbiology, Maharajgunj Medical Campus, Institute of Medicine, Tribhuvan University, Kathmandu 44600, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0951-9621","authenticated-orcid":false,"given":"Naresh","family":"Kumar","sequence":"additional","affiliation":[{"name":"School of Chemistry, Faculty of Science, University of New South Wales, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3842-7563","authenticated-orcid":false,"given":"Mark","family":"Willcox","sequence":"additional","affiliation":[{"name":"School of Optometry and Vision Science, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,16]]},"reference":[{"key":"ref_1","first-page":"579","article-title":"Antibiotic therapy for ocular infection","volume":"161","author":"Snyder","year":"1994","journal-title":"West J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Panda, S.K., Buroni, S., Swain, S.S., Bonacorsi, A., da Fonseca Amorim, E.A., Kulshrestha, M., da Silva, L.C.N., and Tiwari, V. (2022). Recent advances to combat ESKAPE pathogens with special reference to essential oils. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.1029098"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/ceo.14113","article-title":"Infectious keratitis: A review","volume":"50","author":"Khoo","year":"2022","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101031","DOI":"10.1016\/j.preteyeres.2021.101031","article-title":"Bacterial keratitis: Identifying the areas of clinical uncertainty","volume":"89","author":"Tuft","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11908-018-0654-5","article-title":"Acinetobacter Infections in Neonates","volume":"20","author":"Zarrilli","year":"2018","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Nunes, P.H.S., Valiatti, T.B., Santos, A.C.D.M., Nascimento, J.A.D.S., Santos-Neto, J.F., Rocchetti, T.T., Yu, M.C.Z., Hofling-Lima, A.L., and Gomes, T.A.T. (2022). Evaluation of the Pathogenic Potential of Escherichia coli Strains Isolated from Eye Infections. Microorganisms, 10.","DOI":"10.3390\/microorganisms10061084"},{"key":"ref_7","first-page":"332","article-title":"The invasive Klebsiella pneumoniae syndrome: Case series","volume":"17","author":"Chelvaraj","year":"2022","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/cid\/cis189","article-title":"Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis","volume":"54","author":"Lalitha","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1167\/iovs.09-3933","article-title":"Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis","volume":"51","author":"Kaye","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/20477724.2021.1916158","article-title":"Foodborne ESKAPE Biofilms and Antimicrobial Resistance: Lessons Learned from Clinical Isolates","volume":"115","author":"Patil","year":"2021","journal-title":"Pathog. Glob. Health"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s004170050215","article-title":"The combination of topical ceftazidime and aminoglycosides in the treatment of refractory pseudomonal keratitis","volume":"237","author":"Robinson","year":"1999","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ophtha.2018.10.018","article-title":"Bacterial Keratitis Preferred Practice Pattern\u00ae","volume":"126","author":"Lin","year":"2019","journal-title":"Ophthalmology"},{"key":"ref_13","first-page":"19","article-title":"Cefazolin-Gentamicin versus Vancomycin-Ceftazidime Eye Drops for Bacterial Corneal Ulcers: A Randomized Clinical Trial","volume":"4","author":"Dehghani","year":"2009","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"R93740","DOI":"10.7554\/eLife.93740.3","article-title":"The effect of combining antibiotics on resistance: A systematic review and meta-analysis","volume":"13","author":"Siedentop","year":"2024","journal-title":"eLife"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Taheri-Araghi, S. (2024). Synergistic action of antimicrobial peptides and antibiotics: Current understanding and future directions. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1390765"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/med.21879","article-title":"Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections","volume":"42","author":"Zhu","year":"2022","journal-title":"Med. Res. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Otvos, J.L., Ostorhazi, E., Szabo, D., Zumbrun, S.D., Miller, L.L., Halasohoris, S.A., Desai, P.D., Int Veldt, S.M., and Kraus, C.N. (2018). Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo. Front. Chem., 6.","DOI":"10.3389\/fchem.2018.00309"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Mohammed, I., Said, D.G., Nubile, M., Mastropasqua, L., and Dua, H.S. (2019). Cathelicidin-Derived Synthetic Peptide Improves Therapeutic Potential of Vancomycin Against Pseudomonas aeruginosa. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02190"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Liu, J., Chen, F., Wang, X., Peng, H., Zhang, H., and Wang, K.J. (2020). The Synergistic Effect of Mud Crab Antimicrobial Peptides Sphistin and Sph(12-38) with Antibiotics Azithromycin and Rifampicin Enhances Bactericidal Activity Against Pseudomonas Aeruginosa. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.572849"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Yasir, M., Dutta, D., and Willcox, M.D.P. (2020). Activity of Antimicrobial Peptides and Ciprofloxacin against Pseudomonas aeruginosa Biofilms. Molecules, 25.","DOI":"10.3390\/molecules25173843"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kampshoff, F., Willcox, M.D.P., and Dutta, D. (2019). A Pilot Study of the Synergy between Two Antimicrobial Peptides and Two Common Antibiotics. Antibiotics, 8.","DOI":"10.3390\/antibiotics8020060"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.clae.2017.01.002","article-title":"Activity of a melimine-derived peptide Mel4 against Stenotrophomonas, Delftia, Elizabethkingia, Burkholderia and biocompatibility as a contact lens coating","volume":"40","author":"Dutta","year":"2017","journal-title":"Cont. Lens Anterior Eye"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/OPX.0000000000001282","article-title":"Development of Silicone Hydrogel Antimicrobial Contact Lenses with Mel4 Peptide Coating","volume":"95","author":"Dutta","year":"2018","journal-title":"Optom. Vis. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kalaiselvan, P., Dutta, D., Konda, N., Vaddavalli, P.K., Sharma, S., Stapleton, F., and Willcox, M.D. (2022). Biocompatibility and Comfort during Extended Wear of Mel4 Peptide-Coated Antimicrobial Contact Lenses. Antibiotics, 11.","DOI":"10.3390\/antibiotics11010058"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cmi.2020.12.009","article-title":"Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins","volume":"27","author":"Wagenlehner","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/nm1306","article-title":"Dysregulation of bacterial proteolytic machinery by a new class of antibiotics","volume":"11","author":"Beyer","year":"2005","journal-title":"Nat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JCM.00213-21","article-title":"Overview of changes to the Clinical and Laboratory Standards Institute performance standards for antimicrobial susceptibility testing, M100","volume":"59","author":"Humphries","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_28","unstructured":"Wani, M.Y., and Ahmad, A. (2020). Chapter 12\u2014New Approaches for Targeting Drug Resistance Through Drug Combination. Combination Therapy Against Multidrug Resistance, Academic Press."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Zharkova, M.S., Komlev, A.S., Filatenkova, T.A., Sukhareva, M.S., Vladimirova, E.V., Trulioff, A.S., Orlov, D.S., Dmitriev, A.V., Afinogenova, A.G., and Spiridonova, A.A. (2023). Combined Use of Antimicrobial Peptides with Antiseptics against Multidrug-Resistant Bacteria: Pros and Cons. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010291"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1038\/s41598-018-23321-6","article-title":"CISNE: An accurate description of dose-effect and synergism in combination therapies","volume":"8","author":"Ferrer","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Pizzolato-Cezar, L.R., Okuda-Shinagawa, N.M., and Machini, M.T. (2019). Combinatory Therapy Antimicrobial Peptide-Antibiotic to Minimize the Ongoing Rise of Resistance. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.01703"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/ICO.0000000000000184","article-title":"Use of topical colistin in multidrug-resistant Pseudomonas aeruginosa bacterial keratitis","volume":"33","author":"Jain","year":"2014","journal-title":"Cornea"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1038\/s41598-019-42440-2","article-title":"Comparative mode of action of the antimicrobial peptide melimine and its derivative Mel4 against Pseudomonas aeruginosa","volume":"9","author":"Yasir","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.plipres.2011.12.005","article-title":"Role of lipids in the interaction of antimicrobial peptides with membranes","volume":"51","author":"Teixeira","year":"2012","journal-title":"Prog. Lipid Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/21505594.2017.1313372","article-title":"Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action","volume":"9","author":"Roy","year":"2018","journal-title":"Virulence"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Andrea, A., Molchanova, N., and Jenssen, H. (2018). Antibiofilm Peptides and Peptidomimetics with Focus on Surface Immobilization. Biomolecules, 8.","DOI":"10.3390\/biom8020027"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Campoccia, D., Bottau, G., De Donno, A., Bua, G., Ravaioli, S., Capponi, E., Sotgiu, G., Bellotti, C., Costantini, S., and Arciola, C.R. (2024). Assessing Cytotoxicity, Proteolytic Stability, and Selectivity of Antimicrobial Peptides: Implications for Orthopedic Applications. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413241"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/cid\/ciae052","article-title":"Extensively Drug-Resistant Pseudomonas aeruginosa Outbreak Associated with Artificial Tears","volume":"79","author":"Grossman","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Shang, D., Liu, Y., Jiang, F., Ji, F., Wang, H., and Han, X. (2019). Synergistic Antibacterial Activity of Designed Trp-Containing Antibacterial Peptides in Combination with Antibiotics Against Multidrug-Resistant Staphylococcus epidermidis. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02719"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"101819","DOI":"10.1016\/j.clae.2023.101819","article-title":"Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates","volume":"46","author":"Khan","year":"2023","journal-title":"Cont. Lens Anterior Eye"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"104574","DOI":"10.1016\/j.meegid.2020.104574","article-title":"Acquired fluoroquinolone resistance genes in corneal isolates of Pseudomonas aeruginosa","volume":"85","author":"Khan","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jtos.2025.10.011","article-title":"Phenotypic and genotypic profiling of antimicrobial resistance genes and virulence factors in Pseudomonas aeruginosa isolates from keratitis patients","volume":"38","author":"Tigabu","year":"2025","journal-title":"Ocul. Surf."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Fajardo-Lubi\u00e1n, A., Ben Zakour, N.L., Agyekum, A., Qi, Q., and Iredell, J.R. (2019). Host adaptation and convergent evolution increases antibiotic resistance without loss of virulence in a major human pathogen. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007218"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"lxaf031","DOI":"10.1093\/jambio\/lxaf031","article-title":"Antimicrobial activity of peptoids against Metallo-\u03b2-lactamase-producing Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and other WHO priority pathogens, including Candida auris","volume":"136","author":"Mishra","year":"2025","journal-title":"J. Appl. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.9.5.2","article-title":"Susceptibility of Contact Lens-Related Pseudomonas aeruginosa Keratitis Isolates to Multipurpose Disinfecting Solutions, Disinfectants, and Antibiotics","volume":"9","author":"Khan","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1128\/AAC.14.5.731","article-title":"Minimum bactericidal concentration of sulfamethoxazole-trimethoprim for Haemophilus influenzae: Correlation with prophylaxis","volume":"14","author":"Kirven","year":"1978","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2217\/fmb-2020-0204","article-title":"Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates","volume":"16","author":"Morroni","year":"2021","journal-title":"Future Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the checkerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_49","unstructured":"Wayne, P. (2020). CLSI Supplement M100, Clinical and Laboratory Statandard Institute."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Yasir, M., Dutta, D., and Willcox, M.D.P. (2021). Enhancement of Antibiofilm Activity of Ciprofloxacin against Staphylococcus aureus by Administration of Antimicrobial Peptides. Antibiotics, 10.","DOI":"10.20944\/preprints202108.0451.v1"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Yasir, M., Dutta, D., and Willcox, M.D.P. (2019). Mode of action of the antimicrobial peptide Mel4 is independent of Staphylococcus aureus cell membrane permeability. PLoS ONE, 14.","DOI":"10.1101\/603712"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Lu, Y., Tian, H., Chen, R., Liu, Q., Jia, K., Hu, D.-L., Chen, H., Ye, C., Peng, L., and Fang, R. (2022). Synergistic Antimicrobial Effect of Antimicrobial Peptides CATH-1, CATH-3, and PMAP-36 with Erythromycin Against Bacterial Pathogens. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.953720"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1365-2672.2008.03942.x","article-title":"A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses","volume":"105","author":"Willcox","year":"2008","journal-title":"J. Appl. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Kuppusamy, R., Yasir, M., Yu, T.T., Voli, F., Vittorio, O., Miller, M.J., Lewis, P., Black, D.S., Willcox, M., and Kumar, N. (2023). Tuning the Anthranilamide Peptidomimetic Design to Selectively Target Planktonic Bacteria and Biofilm. Antibiotics, 12.","DOI":"10.3390\/antibiotics12030585"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/8\/793\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:30:53Z","timestamp":1786969853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/8\/793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,16]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["antibiotics15080793"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15080793","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,16]]}}}